Skip to main content
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale logoLink to The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale
. 2015 Nov-Dec;26(6):313–318. doi: 10.1155/2015/702615

Edwardsiella tarda bacteremia. A rare but fatal water- and foodborne infection: Review of the literature and clinical cases from a single centre

Yuji Hirai 1,2,, Sayaka Asahata-Tago 1, Yusuke Ainoda 1, Takahiro Fujita 1, Ken Kikuchi 1
PMCID: PMC4692300  PMID: 26744588

Risk factors of Edwardsiella tarda bacteremia are not well established. Analyzing previous reports and recent clinical cases to determine these risk factors, and examine the distribution and clinical epidemiology of Edwardsiella tarda bacteremia is important because although occurrence is rare, it can be fatal in humans.

Keywords: Bacteremia, Edwardsiella tarda, Foodborne infection, Food habits, Liver cirrhosis, Risk factors, Waterborne infection

Abstract

BACKGROUND:

Edwardsiella tarda bacteremia (ETB) can be a fatal disease in humans.

OBJECTIVES:

To determine the significant risk factors associated with death caused by ETB, and to examine the geographical, seasonal, environmental and dietary factors of the disease.

METHODS:

A retrospective, observational, case control study was performed. The PubMed MEDLINE and Japanese Medical Abstract Society (www.jamas.or.jp) databases were searched for ETB case reports and meeting abstracts. In additon, retrospective chart reviews of patients with ETB at the Tokyo Women’s Medical University Hospital (Tokyo, Japan) were conducted to evaluate the risk factors associated with death using multivariate analyses.

RESULTS:

The literature search yielded 46 publications, comprising 72 cases from the English (n=30), French (n=1), Spanish (n=1) and Japanese (n=14) literature. Five cases at the Tokyo Women’s Medical University Hospital were also included. Of the included 77 cases, the mean age was 61 years and 39% of patients were female; 77.2% of the cases occurred between June and November, and 45.5% were reported in Japan. Dietary factors (raw fish/meat exposure) were reported for 10.4% of patients and 12.9% reported environmental (ie, brackish water) exposure. The overall mortality rate was 44.6%; however, this rate increased to 61.1% for ETB patients with soft tissue infections. Liver cirrhosis was determined to be an independent risk factor associated with death (OR 12.0 [95% CI 2.46 to 58.6]; P=0.00213) using multivariate analyses.

DISCUSSION:

To our knowledge, the present analysis was the first and largest multi-language review of ETB. Clinical characteristics of ETB resemble those of Aeromonas, typhoid fever and Vibrio vulnificus infections, in addition to sharing similar risk factors.

CONCLUSION:

ETB should be categorized as a severe food- and waterborne infection, which results in high mortality for patients with liver cirrhosis.


Edwardsiella tarda is a motile, facultatively anaerobic, Gram-negative rod that is categorized as a member of the family Enterobacteriaceae. The genus Edwardsiella was first recognized by Trabulsi et al (1) in 1962, followed by a description of E tarda in the mid-1960s. These organisms have successively been named the “Bartholomew group” by King and Adler (2), the “Asakusa group” by Sakazaki (3) and “Edwardsiella” by Ewing et al (4).

E tarda is typically isolated from fresh or brackish water environments such as river mouths. It has also been isolated from the intestines of humans (after eating fresh water food sources such as catfish [5] or eels [6]) and from animals, including reptiles and freshwater fish.

E tarda rarely causes infections in humans. The colonization rate in humans ranges from 0.0073% in the Japanese (7) to 1% in Panamanians (8). Approximately 80% of E tarda infections in humans are characterized as gastroenteritis and E tarda is primarily isolated from stool samples. Extraintestinal infections, such as endocarditis, empyema, hepatobiliary infections, peritonitis, intra-abdominal abscesses, osteomyelitis, wound infections and meningitis, have been reported less frequently. While E tarda bacteremia (ETB) occurs relatively rarely (<5%), it can be fatal in humans (9). However, little is known about the clinical epidemiology of ETB. Therefore, we aimed to document the clinical epidemiology of ETB, including independent risk factors associated with death, the geographical and seasonal distributions, as well as environmental and dietary risks, based on previous reports and recent clinical cases of ETB at our institution (Tokyo Women’s Medical Univeristy [TWMU] Hospital [Tokyo, Japan]).

METHODS

A retrospective, observational, case control study was performed. The present analysis comprised literature and retrospective chart reviews. A search was conducted for case reports and case series involving ETB, published between January 1968 and December 2013, with the PubMed MEDLINE and Japanese Medical Abstracts Society ICHUSHI (www.jamas.or.jp) databases using the following keywords: “Edwardsiella tarda”, “E tarda” and “infection”. An episode of ETB was defined as ≥1 positive blood cultures yielding E tarda from the same patient. Results meeting the following criteria were included: published case reports or abstracts from scientific meetings; patients of any age; and articles published in any language including English, French, Spanish and Japanese. Exclusion criteria included: negative blood culture; no description of E tarda infection; animal cases; experimental studies; and review articles.

In addition, the medical records of patients, regardless of age, with ETB admitted to the TWMU (a 1423-bed university hospital in Tokyo, Japan) between April 2000 and December 2013, were included in the retrospective chart review.

The following data were obtained from both published and TWMU-admitted cases that fulfilled the inclusion criteria: age; sex; underlying disease; antibiotic treatment; complications related to the ETB; geographical area; month of ETB onset; history of exposure to environmental risk factors; dietary history to include dietary risk factors; and crude mortality after ETB within 90 days. The case definition for survival required a report of whether the patient survived, or no report of death, in published articles or medical records from cases at TWMU. During the study period, 112,796 blood samples were obtained under sterile conditions and were processed using BACTEC 9240 (Becton Dickinson Diagnostic Instrument Systems, USA) until March 11, 2011, and BacT/ALERT 3D (bioMérieux, France) from April 2011 onward. Strains of E tarda were identified using MicroScan WalkAway 96si (Siemens, Germany). The five cases of ETB identified were included in the present study. The species identification of E tarda was also confirmed using matrix-assisted laser desorption ionization–time of flight mass spectrometry (Microflex LT with MALDI-Biotyper version 3.1, Bruker Daltonik, Germany). Susceptibility of E tarda isolated from blood cultures was tested retrospectively in accordance with the standards of the Clinical and Laboratory Standards Institute using E-test (bioMérieux, France).

Continuous data were compared using a t test and categorical data were compared using Fisher’s exact tests; P<0.05 was considered to be statistically significant. Multivariate analyses were used to determine the independent risk factors associated with mortality using forward stepwise logistic regression. All variables with P<0.1 in univariate analyses were entered into the multivariate model. Statistical analyses were performed using R version 3.0.3 (www.r-project.org).

The study protocol was approved by the TWMU Hospital Medical Ethics Committee (No. 3052).

RESULTS

The literature search resulted in 234 articles from the PubMed MEDLINE database and 68 articles from the ICHUSHI database, published between January 1968 and December 2013. Of these, 202 and 54 publications were excluded, according to inclusion criteria, from the PubMed MEDLINE and ICHUSHI databases, respectively. The resulting 46 publications, published between 1968 and 2013, were retrieved from the English (n=30) (837), French (n=1) (38), Spanish (n=1) (39) and Japanese (n=14) literature (4053). A total of 72 cases were described in the retrieved publications and five cases diagnosed at the TWMU were also included, resulting in 77 cases for analysis.

The mean age of the patients was 61 years (range two days to 101 years) and 30 cases (30 of 77 [39%]) involved women. Underlying diseases included cancer (29 of 77 [37.6%]); hepatobiliary cancer (17 of 77 [20.8%]) and liver cirrhosis (13 of 77 [16.8%]). Six (6.5%) cases involved neonatal patients. Thirteen (16.9%) cases occurred in healthy individuals without any underlying disease and there were 35 (45.5%) cases of uncomplicated ETB. Eighteen (23.4%) cases involved soft tissue infections, 24.7% involved diarrhea, 13.0% involved liver abscess and 3.9% involved meningitis. Despite appropriate antimicrobial therapy, the overall mortality rate was 44.6% (33 of 74, no mortality data available for three cases [14,46,49]); however, this rate increased to 61.1% (11 of 18) for patients with soft tissue infections.

Treatment using the following antimicrobial agents was described in 51 cases (66.2%): cephalosporin (n=26), penicillin (n=19) and carbapenems (n=8). Although no significant differences were found with respect to age, sex, complications of ETB, geographical area or season of onset among cases in which the patient died compared with cases in which the patient survived, liver cirrhosis (OR 12.0 [95% CI 2.46 to 58.6]; P=0.00213) was considered to be an independent risk factor associated with death in multivariate analyses (Table 1). Antibiotic susceptibility of the E tarda strains that were isolated from the blood cultures is summarized in Table 2. Six cases in the literature reported susceptibility to ampicillin, cefazolin, imipenem, levofloxacin and gentamicin, in cases in which each drug minimum inhibitory concentrations were measured (13,18,39,41,42,5153). Reduced susceptibility to colistin was found in four of five strains (80%) at the TWMU and two of two strains (13,18) in the literature. Reported environmental risks included direct exposure to fresh or brackish water (lacerated forearm after a fall into brackish water [28] and fishing [28,36]), soil (farming [8] and gardening [12]) and animal feces (working in a zoo [20]). The parents of two neonatal cases were exposed to fresh water; the father from one case was a dock maintenance worker at a lake and his wife participated in a baptism involving immersion in a lake while pregnant, and a mother from another case washed clothes in a river resulting in confirmed maternal colonization (29,50). Reported dietary risks included exposure to raw fish/sushi (48,50,51) (TWMU-5 in Table 2), raw meat (27), ceviche during a trip to Ecuador (45) and unpasteurized goat’s milk (46). The geographical distribution of ETB is shown in Figure 1. The most frequently reported geographical area of ETB cases was Japan (35 of 77 [45.5%]) (21,32,37,4053) (TWMU-1, −2, −3, −4, −5 in Table 2), followed by the United States (US) (12 of 77 [15.6%]) and the Republic of China (Taiwan) (10 of 77 [13.0%]). Five of 12 (41.6%) cases from the US occurred in states located around the Gulf of Mexico (Louisiana, n=2 [12,32]; Florida, n=1 [15]; Texas, n=1 [18]; and Mississippi, n=1 [24]). Of the cases from the US, 66.7% (eight of 12) occurred in states by the ocean (five cases near the Gulf of Mexico (12,15,18,24,32); New York, n=2 [22,33]; and California, n=1 [13]). No reports of ETB cases in the southern hemisphere were found in the present review. The seasonal distribution of ETB is shown in Figure 2. The majority of the cases that provided a description of the time of onset (18 of 22 [81.8%]) (10,12,13,15,16,18,21,25,28,33,38,4042,45,50,51) (TWMU-1, −2, −3, −4, −5 in Table 2) occurred during the northern hemisphere summer and autumn months (June to November).

TABLE 1.

Clinical characteristics of 77 patients with Edwardsiella tarda bacteremia (ETB)

Overall n (%) Survived, n Died, n Univariate analysis Multivariate analysis P


P OR (95% CI)
Cases, n 77 44 33
Age, years, mean (range) OR mean ± SD 61 (2 days – 101 years) 54.02±26.2 55.9±24.4 0.75
>65 years of age 31 (40.3) 17 14 0.818
<1 year of age 6 (7.8) 3 3 1
Female sex 30 (39.0) 20 10 0.166
Underlying diseases
Cancer 29 (37.7) 13 16 1
  Hepatobiliary cancer 17 (22.1) 6 11 0.0531 3.2 (0.76 – 13.4) 0.111
  Gastric/colon cancer 5 (6.5) 3 2 1
Noncancer
  Liver cirrhosis 13 (16.9) 2 11 0.000567 12.0 (2.46 – 58.6) 0.00213
  Galbladder stone, chorecystitis 21 (27.3) 16 5 0.0434 0.351 (0.104 – 1.19) 0.093
  Diabetes 7 (9.1) 2 5 0.131
Complication of ETB
  Meningitis 4 (5.2) 1 3 0.308
  Liver abscesss 10 (13.0) 7 3 0.502
  Diarrhea 19 (24.7) 13 6 0.295
  Soft tissue infection 18 (23.4) 7 11 0.103
  Intrauterine infection 3 (3.9) 3 0 0.3498
  No complication 35 (45.5) 21 14 0.817
Antimicrobial agents
Penicillins 19 (24.7) 12 7 0.398
Cepharosporins 26 (33.8) 15 11 0.781
Carbapebens 8 (10.4) 4 4 1
Others (eg, aminoglycosides) 16 (20.8) 10 6 0.104
Behavior/dietary risk factors
Alcoholism 5 (6.5) 3 2 1
Exposure
  To raw food 8 (10.4) 6 2 0.454
  To fresh or marine water, animal feces 10 (13.0) 6 4 1
Geographical area
Japan 35 (45.5) 19 16 0.653
United States (US) 12 (15.6) 9 3 0.216
  States around the Gulf of Mexico 5 (6.5) 4 1 1
Republic of China (Taiwan) 10 (13.0) 6 4 1
Other region (Not Japan, US, Taiwan) 19 (24.7) 9 10 0.104
Season of onset (northern hemisphere)
Summer (June to November) 18 (23.4) 13 5 0.117
Period of time from onset to patient dying 20 h – 61 days (median 8 days)

TABLE 2.

Antimicrobial susceptibility of Edwardsiella tarda isolated from blood culture; five cases from Tokyo Women’s Medical University (TWMU; Tokyo, Japan) and eight cases from the literature

Age, years/sex Underlying disease(s) Complication Exposure/dietary risk Minimum inhibitory concentration (MIC), mg/L TWMU case or reference Country Year

ABPC CEZ CTX IPM/CS GM LVFX TMP-SMX Colistin
88/female GBS Cholecystitis ND <2 <2 <8 <1 <1 <0.5 <2 16 (R) TWMU-1 Japan 2004
80/male LC, HCC EC ND <2 <2 <8 <1 <1 <0.5 <2 24 (R) TWMU-2 Japan 2004
84/male BCa Cholecystitis ND <4 <4 <8 <1 <1 <2 <2 32 (R) TWMU-3 Japan 2010
80/female PCa Liver abscess ND <4 <4 <8 <1 <1 <2 <2 0.125 (S) TWMU-4 Japan 2013
46/female Ce-Ca EC Sushi <4 <4 <8 <1 <1 <2 <2 32 (R) TWMU-5 Japan 2013
14/female none Liver abscess Immigrant S ND ND ND ND ND ND R 13 Thailand 1969
46/male none EC Travel to Mexico 0.25 1 (cefalothin) ND ND 0.25 ND ND R 18 United States 1980
39/male Alcoholism EP, DC ND S S S S S S S ND 41 Japan 1988
67/male HCC, LC NF ND S S S S S S S ND 42 Japan 1996
76/male DM, HCC Liver abscess Sushi ND <8 <8 (CAZ) <1 (MEPM) <16 (AMK) <2 ND ND 51 Japan 2011
21/female SCA None ND <2 <4 <0.5 <1 2 <0.25 <2 ND 39 Columbia 2008
46/female SLE PID ND <2 <4 <1 <1 <1 <0.12 ND ND 53 Japan 2012
67/female NHL NF ND <4 <4 <8 <1 <1 <1 <2 ND 52 Japan 2012

ABPC Ampicillin; AMK Amoxicillin; BCa Bile duct cancer; CAZ Ceftazidime; Ce-Ca Cervical cancer; CEZ Cefazolin; CTX Cefotaxime; DC Discitis; DM Diabetes mellitus; EC Endstage cancer; EP Endophthalmitis; GBS Gallbladder stone; GM Gentamicin; HCC Hepatiocellular carcinoma; IPM/CS Imipenem cilastatin; LC Liver cirrhosis; LVFX Levofloxacin; MEPM Meropenem; ND Not described; NF Neurofibromatosis; NHL Non-Hodgkin lymphoma; PCa Pancreatic cancer; PID Pelvic inflammatory disease; R Resistant (MIC not described); S Susceptible (MIC not described); SCA Sickle cell anemia; SLE Systemic lupus erythematosus; TMP-SMX Trimethoprim/sulfamethoxazole

Figure 1).

Figure 1)

Number (No) of Edwardsiella tarda bacteremia cases according to location on the world map. TWMU Tokyo Women’s Medical University, Tokyo, Japan

Figure 2).

Figure 2)

The seasonal distribution of 22 Edwardsiella tarda bacteremia cases. Apr April; Aug August; Dec December; Feb February; Jan January; Jul July; Jun June; Mar March; Oct October; Sept September; Nov November

DISCUSSION

To our knowledge, the present study was the first and largest multi-language review of ETB. The results indicate that the overall mortality related to ETB is 44.6%, and ETB may be more likely to occur in the humid and subtropical climates of Eastern Asia and near the Gulf of Mexico in the US, particularly during summer and autumn months. Furthermore, environmental and dietary risk factors, such as exposure to brackish water and raw food consumption, may play a role in ETB.

ETB occurs infrequently (<5%) (9), and the risk factors are not well established. Investigating similarities with other species may provide some clues regarding the mechanisms related to ETB. Previous case series suggest that up to 50% of ETB patients also had hepatobiliary diseases, including alcoholic cirrhosis (9). Interestingly, the authors indicated that conditions resulting in iron overload, such as cirrhosis, sickle cell anemia, leukemia and the neonatal state, are also considered to be risk factors for ETB (9). In the present analysis, 66.2% of the cases involved hepatobiliary diseases, including cancer. Twenty-one (27.3%) of these cases involved gallbladder stones with recurrent episodes of cholecystitis. The rate of underlying diseases may be higher in ETB than in other E tarda infections; this may indicate that the presence of underlying disease increases the risk for developing ETB. However, the results of our multivariate analyses suggest, for the first time, that liver cirrhosis is an independent risk factor associated with death in ETB. Cholecystitis with gallbladder stones may increase the risk for ETB in a way similar to that of human typhoid fever. Moreover, the overall rate of underlying diseases in ETB may be higher than in other E tarda infections, potentially indicating that the presence of underlying disease increases the risk for ETB and subsequent high mortality from ETB.

In addition, reservoir-related Aeromonas species are similar to E tarda. Both can cause a wide spectrum of diseases among warm- and cold-blooded animals, including fish, reptiles, amphibians, mammals and humans. Population sizes of both species can grow quite large, generally peaking in the warmer temperatures of the summer months in temperate freshwater lakes and chlorinated drinking water, and have been associated with contact wtih reptiles, including those kept as pets (54). Vibrio vulnificus can also cause severe disseminated infection associated with exposure to seawater and brackish water. Severe V vulnificus infections in humans are also responsible for liver cirrhosis. Therefore, clinical characteristics of E tarda infections in humans resemble those of Aeromonas, typhoid fever and V vulnificus infections, and share similar environmental risks. It is well known that necrotizing fasciitis type 3, which is known as a marine infection and can be fatal within 48 h, is caused by Vibrio or Aeromonas species. Therefore, it should be recognized that E tarda can also result in necrotizing fasciitis type 3. In addition, previous reports indicate that the mortality rate of ETB is nearly 50%, which is similar to that of V vulnificus (55) or severe infections caused by Aeromonas species (56,57).

E tarda infections, including ETB, are considered to be foodborne. Despite this, dietary risk factors for ETB have not been well established or documented. In addition, most of the cases of ETB are suspected to occur endogenously through primary colonization and infection in the human intestinal tract. However, documented E tarda infections in humans have resulted from the consumption of infected or contaminated food such as fish (58). According to the Food and Agriculture Organization of the United Nations Statisitcs Division (FAOSTAT) Food Balance Sheet 2006 (http://faostat.fao.org/), Japan has one of the world’s highest per capita seafood consumption rates. E tarda has been isolated from raw flounder in Japanese fish farms (58). Interestingly, E tarda has been reported to result in a 60% to 90% mortality rate among Japanese eels (59), and a traditional custom in Japan, dating from the 18th century, is to eat cooked eel at the end of July. Furthermore, 71% of the eels from the eel farms in Korea (60) have been reported to carry E tarda.

Toward the end of the 1960s in the US, E tarda was linked to catfish, mainly in the waters of Arkansas, Mississippi, Texas and Louisiana (61). Despite the small number of cases in the current study, approximately one-half of the cases occurred around the Gulf of Mexico, which receives a supply of nutrient-rich water from several rivers. Individuals residing in these areas may be exposed to high concentrations of E tarda through the water or contaminated food. According to data from the National Fisheries Institute, tilapia, pangasius and catfish are consumed in the US. They are farmed in fresh water and 79% of already-dressed catfish in the US carry E tarda (62). Given the collective findings of the available literature, we suspect that dietary exposures also affect the risk for ETB.

Little is known about the recent prevalence of E tarda colonization in healthy individuals; no recent data are available from large-scale studies in any country. A study conducted in the 1970s (7), is one of the few to report that only 26 of 353,600 Japanese individuals were healthy carriers of E tarda. We suspect that the rate of colonization in stool appears to be high among individuals in areas with a high consumption of raw fish contaminated with E tarda. The colonization rate in humans may be affected by changes in dietary habits and increased travel, and the use of novel techniques, such as matrix-assisted laser desorption ionization–time of flight mass spectrometry, may improve identification of E tarda, which was previously underestimated.

Trimethoprim/sulfamethoxazole-resistant E tarda has been clinically isolated in a pediatric patient with X-linked chronic granulomatous disease and osteomyelitis in Japan (63). No multidrug-resistant strains of E tarda were found in the current study. There are several studies showing at least 90% of E tarda strains to be colistin resistant. Natural resistance of E tarda to colistin or polymyxin B has been suggested, but its mechanism was unelucidated (64). Feedstuffs for domesticated animals are exposed to colisin in Japan (65) and some European countries. Antibiotic resistance in E tarda may emerge as an issue related to environmental antibiotic exposure in food production. Geographical differences among the Republic of China (Taiwan) and the US in the antimicrobial susceptibility of E tarda, isolated from food-producing animals, have been previously described (66). Seasonal distribution of human E tarda gastroenteritis has not been previously demonstrated (9). In addition, information has not been available regarding the time of year for extraintestinal E tarda infections in previously reported cases. The results of the current review suggest that there may, in fact, be a seasonal distribution of ETB, and exposure to higher concentrations of E tarda in the warmer temperatures of the summer months may increase the risk for ETB (61). For example, Eastern Asia, which includes Japan and the Republic of China (Taiwan), and the states of the US near the Gulf of Mexico, reported the highest rates of ETB and belong to climates that are similar – humid and subtropical.

In addition, dietary customs vary according to geographical region. Therefore, dietary factors may play a role in the geographical or seasonal distributions of ETB.

Taking all of this into account, we propose two reasons for the high prevalence of ETB in Japan. The first is that Japan is geographically rich in brackish water areas and rivers. Second, the Japanese consume a relatively large amount of raw seafood, which may be contaminated with E tarda.

The present review had limitations. One was the retrospective nature of the data, including the use of previously reported literature and only five recent cases from our institute. Fourteen of 72 cases from the literature were described only in the Japanese language. Therefore, publication and resource bias may have affected our results. The second limitation is that we focused on the results of blood cultures; however, sensitivity of blood cultures may vary during a long study period.

CONCLUSIONS

ETB may be categorized as a severe food- and waterborne infection similar to Aeromonas, Vibrio and Salmonella (typhoid fever) infections, which result in high mortality in patients with severe underlying diseases such as liver cirrhosis. Geographical and seasonal distributions may characterize ETB. The clinical epidemiology, including dietary risk factors and the current incidence of ETB should be further established.

Acknowledgments

Results from this study were presented, in part, as a poster (Presentation number 1263) at ID Week 2013, San Francisco, October 2 to 6, 2013.

Footnotes

DISCLOSURES: The authors have no financial relationships or conflicts of interest to declare.

REFERENCES

  • 1.Trabulsi LR, Ewing WH. Sodium acetate medium for the differentiation of Shigella and Escherichia cultures. Public Health Lab. 1962;20:137–40. [Google Scholar]
  • 2.King BM, Adler DL. A previously undescribed group of Enterobacteriaceae. Am J Clin Pathol. 1964;41:230–2. [PubMed] [Google Scholar]
  • 3.Sakazaki R. A proposed group of the family Enterobacteriaceae, the Asakusa group. Int Bull Bacteriol Nomencl Taxon. 1965;15:45–7. [Google Scholar]
  • 4.Ewing WH, McWhorter AC, Escobar MR, Lubin AH. Edwardsiella, a new genus of Enterobacteriaceae, based on a new species, E.tarda. Int Bull Bacteriol Nomencl Taxon. 1965;15:33–8. [Google Scholar]
  • 5.Wyatt LE, Nickelson R, Vanderzant C. Edwardsiella tarda in freshwater catfish and their environment. Appl Environ Microbiol. 1979;38:710–4. doi: 10.1128/aem.38.4.710-714.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Joh SJ, KIM MJ, Kwon HM, Ahn EH, Jang H, Kwon JH. Characterization of Edwardsiella tarda isolated from farm-cultured eels, Anguilla japonica, in the Republic of Korea. J Vet Med Sci. 2011;73:7–11. doi: 10.1292/jvms.10-0252. [DOI] [PubMed] [Google Scholar]
  • 7.Onogawa T, Terayama T, Zenyoji H. Distribution of Edwardsiella tarda and hydrogen sulfide-producing Escherichia coli in healthy persons. J Jpn Assoc for Infect Dis (Kansenshogaku Zasshi) 1976;50:10–7. doi: 10.11150/kansenshogakuzasshi1970.50.10. [DOI] [PubMed] [Google Scholar]
  • 8.Kournay M, Vasquez MA, Saenz R. Edwardsiellosis in man and animals in Panama: Clinical and epidemiological characteristics. Am J Trop Med Hyg. 1977;26:1183–90. doi: 10.4269/ajtmh.1977.26.1183. [DOI] [PubMed] [Google Scholar]
  • 9.Janada JM, Sharon LA. Infections associated with the genus Edwardsiella: The role of Edwardsiella tarda in human diseases. Clin Infect Dis. 1993;17:742–8. doi: 10.1093/clinids/17.4.742. [DOI] [PubMed] [Google Scholar]
  • 10.Okubadejo OA, Alausa KO. Neonatal meningitis caused by Edwardsiella tarda. Br Med J. 1968;3:357–8. doi: 10.1136/bmj.3.5614.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sonnenwirth AC, Kallus BA. Meningitis due to Edwardsiella tarda. First report of meningitis caused by E.tarda. Am J Clin Pathol. 1968;49:92–5. doi: 10.1093/ajcp/49.1.92. [DOI] [PubMed] [Google Scholar]
  • 12.Pankey GA, Seshul MB. Septicemia caused by Edwardsiella tarda. J La State Med Soc. 1969;121:41–3. [PubMed] [Google Scholar]
  • 13.Jordan GW, Hadley WK. Human infection with Edwardsiella tarda. Ann Intern Med. 1969;70:283–8. doi: 10.7326/0003-4819-70-2-283. [DOI] [PubMed] [Google Scholar]
  • 14.Bockemühl J, Pan-Urai R, Burkhardt F. Edwardsiella tarda associated with human disease. Pathol Microbiol. 1971;37:393–401. [PubMed] [Google Scholar]
  • 15.Sachs JM, Pacin M, Counts GW. Sickle hemoglobinopathy and Edwardsiella tarda meningitis. Am J Dis Child. 1974;128:387–8. doi: 10.1001/archpedi.1974.02110280117018. [DOI] [PubMed] [Google Scholar]
  • 16.Le Frock JL, Klainer AS, Zuckerman K. Edwardsiella tarda bacteremia. South Med J. 1976;60:188–90. doi: 10.1097/00007611-197602000-00018. [DOI] [PubMed] [Google Scholar]
  • 17.Koshi G, Lalitha MK. Edwardsiella tarda in a variety of human infections. Indian J Med Res. 1976;64:1753–9. [PubMed] [Google Scholar]
  • 18.Clarridge JE, Musher DM, Fainstein V, Wallace RJ., Jr Extraintestinal human infection caused by Edwardsiella tarda. J Clin Microbiol. 1980;11:511–4. doi: 10.1128/jcm.11.5.511-514.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ovartlarnporn B, Chayakul P, Suma S. Edwardsiella tarda infection in Hat Yai Hospital. J Med Assoc Thai. 1986;69:599–603. [PubMed] [Google Scholar]
  • 20.Marínez ML, Lázaro ME, Albillos A, et al. Edwardsiella tarda bacteremia. Eur J Clin Microbiol Infect Dis. 1987;6:599–600. doi: 10.1007/BF02014262. [DOI] [PubMed] [Google Scholar]
  • 21.Funada H, Kameoka J, Machi T, Matsuda T. Edwardsiella tarda septicemia complicating acute leukemia. Jpn J Med. 1987;27:325–8. doi: 10.2169/internalmedicine1962.27.325. [DOI] [PubMed] [Google Scholar]
  • 22.Vohra K, Torrijos E, Jhaveri R, Gordon H. Neonatal sepsis and meningitis caused by Edwardsiella tarda. Pediatr Infect Dis J. 1988;7:814–15. doi: 10.1097/00006454-198811000-00018. [DOI] [PubMed] [Google Scholar]
  • 23.Wilson JP, Waterer RR, Wofford JD, Chapman SW. Serious infections with Edwardsiella tarda. A case report and review of the literature. Arch Intern Med. 1989;149:208–10. [PubMed] [Google Scholar]
  • 24.Jaruratanasirikul S, Kalnauwakul S. Edwardsiella tarda: A causative agent in human infections. Southeast Asian J Trop Med Public Health. 1991;22:30–4. [PubMed] [Google Scholar]
  • 25.Fournier S, Pialoux G, Feuillie V, Fleury J, Dupont B. Edwardsiella tarda septicemia with cellulitis in a patient with AIDS. Eur J Clin Microbiol Infect Dis. 1997;16:551–3. doi: 10.1007/BF01708246. [DOI] [PubMed] [Google Scholar]
  • 26.Osiri M, Tantawichien T, Deesomchock U. Edwardsiella tarda bacteremia and septic arthritis in a patient with diabetes mellitus. Southeast Asian J Trop Med Public Health. 1997;28:669–72. [PubMed] [Google Scholar]
  • 27.Yang CH, Wang CK. Edwardsiella tarda bacteraemia-complicated by acute pancreatitis and pyomyoma. J Infect. 1999;38:124–6. doi: 10.1016/s0163-4453(99)90081-6. [DOI] [PubMed] [Google Scholar]
  • 28.Slaven EM, Lopez FA, Hart SM, Sanders CV. Myonecrosis caused by Edwardsiella tarda: A case report and case series of extraintestinal E.tarda infections. Clin Infect Dis. 2001;32:1430–3. doi: 10.1086/320152. [DOI] [PubMed] [Google Scholar]
  • 29.Mowbray EE, Buck G, Humbaugh KE, Marshall GS. Maternal colonization and neonatal sepsis caused by Edwardsiella tarda. Pediatrics. 2003;111:e296–8. doi: 10.1542/peds.111.3.e296. [DOI] [PubMed] [Google Scholar]
  • 30.Wang IK, Kuo HL, Chen YM, et al. Extraintestinal manifestations of Edwardsiella tarda infection. Int J Clin Pract. 2005;59:917–21. doi: 10.1111/j.1742-1241.2005.00527.x. [DOI] [PubMed] [Google Scholar]
  • 31.Yousuf RM, How SH, Amran M, Hla KT, Shah A, Francis A. Edwardsiella tarda septicemia with underlying multiple liver abscesses. Malays J Pathol. 2006;28:49–53. [PubMed] [Google Scholar]
  • 32.Tamada T, Koganemaru H, Matsumoto K, Hitomi S. Urosepsis caused by Edwardsiella tarda. J Infect Chemother. 2009;15:191–4. doi: 10.1007/s10156-009-0678-8. [DOI] [PubMed] [Google Scholar]
  • 33.Golub V, Kim AC, Krol V. Surgical wound infection, tuboovarian abscess, and sepsis caused by Edwardsiella tarda: Case reports and literature review. Infection. 2010;38:487–9. doi: 10.1007/s15010-010-0057-5. [DOI] [PubMed] [Google Scholar]
  • 34.Kadam SD. Edwardsiella tarda – a case report. Indian J Pediatr. 2013;80:63–4. doi: 10.1007/s12098-011-0590-y. [DOI] [PubMed] [Google Scholar]
  • 35.Hashavya S, Averbuch D, Berger I, et al. Neonatal sepsis following maternal amnionitis by Edwardsiella tarda: A case report and a review of the literature. Eur J Pediatr. 2011;170:111–3. doi: 10.1007/s00431-010-1285-5. [DOI] [PubMed] [Google Scholar]
  • 36.John AM, Prakash JA, Simon EG, Thomas N. Edwardsiella tarda sepsis with multiple liver abscesses in a patient with Cushing’s syndrome. Indian J Med Microbiol. 2012;30:352–4. doi: 10.4103/0255-0857.99503. [DOI] [PubMed] [Google Scholar]
  • 37.Ohara Y, Kikuchi O, Goto T, et al. Successful treatment of a patient with sepsis and liver abscess caused by Edwardsiella tarda. Intern Med. 2012;51:2813–7. doi: 10.2169/internalmedicine.51.7908. [DOI] [PubMed] [Google Scholar]
  • 38.Peyrade F, Bondiau P, Taillan B, Boscagli A, Roa M, Dujardin P. Edwardsellia tarda septicemia in chronic lymphoid leukemia. Rev Med Interne. 1997;18:233–4. doi: 10.1016/s0248-8663(97)89300-9. [DOI] [PubMed] [Google Scholar]
  • 39.Perez RDA, Ramirez AG. Sepsis por Edwardsiella tarda y asociación conanemia falciforme: Reporte de caso y revision de la literature. Medicina & Laboratorio. 2008;14:43–8. [Google Scholar]
  • 40.Mori K, Yamazaki A, Kishikawa E, Sugizaki N, Kume H. A case of sepsis caused by Edwardsiella tarda. J Jpn Assoc Infect Dis (Kansenshogaku Zasshi) 1983;57:273–9. doi: 10.11150/kansenshogakuzasshi1970.57.273. [DOI] [PubMed] [Google Scholar]
  • 41.Harada M, Yoshida H, Oomagari K, Sakai T, Abe H, Tanikawa K. A case of sepsis caused by Edwardsiella tarda complicated panophthalmitis and pyogenic spondylitis. J Jpn Assoc Infect Dis (Kansenshogaku zasshi) 1990;64:620–4. doi: 10.11150/kansenshogakuzasshi1970.64.620. [DOI] [PubMed] [Google Scholar]
  • 42.Matsushima S, Yajima S, Taguchi T, et al. A fulminating case of Edwardsiella tarda septicemia with necrotizing fasciitis. J Jpn Assoc Infect Dis (Kansenshogaku zassshi) 1996;70:631–6. doi: 10.11150/kansenshogakuzasshi1970.70.631. [DOI] [PubMed] [Google Scholar]
  • 43.Tohira H, Yokota J. Edwardsiella tarda. Nihon rinsho. 2001;(Suppl 1):235–8. [PubMed] [Google Scholar]
  • 44.Maruge S, Mizuguchi M, Yasuda T, et al. A case of necrotizing fasciitis with septic shock due to Edwadsiella tarda. J Jpn Assoc Infect Dis (Kansenshogaku Zasshi) 2005;79(Suppl 1):228. [Google Scholar]
  • 45.Fujimoto M, Nakao K, Fujikawa K, et al. A case of rapidly progressive fatal septic shock following necrotizing fascilitis due to Edwardsiella tarda with hepatitis C virus related liver cirrhosis complicated hepatocellarcarcinoma. Kanzo. 2006;47:273–4. [Google Scholar]
  • 46.Nishiyama H, Tarumoto K, Fujikawa K. A case of necrotizing fasciitis due to Edwardsiella tarda. J Jpn Soc Clin Microbiol. 2007;17(Suppl 1):130. [Google Scholar]
  • 47.Takahashi K, Ikeda M, Matsubayashi H, et al. Intrauterine infection caused by Edwardsiella tarda. Kanto Journal of Obstetrics and Gynecology. 2007;44:73–6. [Google Scholar]
  • 48.Tamura T, Ito K, Tsuchiya R, et al. A case of septic shock with necrotizing fascilitis caused by Edwardsiella tarda. J Jpn Soc Care Med. 2009;16:207–8. [Google Scholar]
  • 49.Fujii M, Ooki T, Yoshiko M. A case of necrotizing fasciculitis caused by E.tarda in a patient with peritoneal dialysis. J Jpn Soc Dial Ther. 2009;(Suppl 42):739. [Google Scholar]
  • 50.Hara K, Ouchi H, Kitahara M, Shibano K, Miyauchi T, Ishiguro H. A case of fasciitis localized in the calf muscles associated with Edwardsiella tarda sepsis. Clin Neurol (Rinsho Shinkeigaku) 2011;51:694–8. doi: 10.5692/clinicalneurol.51.694. [DOI] [PubMed] [Google Scholar]
  • 51.Tokunaga S, Tanino T, Koda M, et al. A case of sepsis due to Edwardsiella tarda with alcoholic liver cirrhosis complicated by hepatocellular carcinoma and lung cancer. Kanzo. 2011;52:120–5. [Google Scholar]
  • 52.Sato M, Satomura H, Odaka I. Septic shock caused by Edwardsiella tarda. Journal of Chiba Association of Medical Technologists. 2012;115:56–9. [Google Scholar]
  • 53.Tanaka C, Nishikawa N, Mushika M, et al. Intrauterine infection which caused sepsis by Edwardsiella tarda. Tokai J Obstet Gynecol. 2013;49:285–9. [Google Scholar]
  • 54.Nagel P, Serritella A, Layden TJ. Edwardsiella tarda gastroenteritis associated with a pet turtle. Gastroenterology. 1982;82:1436–7. [PubMed] [Google Scholar]
  • 55.Matsumoto K, Ohshige K, Fujita N, et al. Clinical features of Vibrio vulnificus infections in the coastal areas of the Ariake Sea, Japan. J Infect Chemother. 2010;16:272–9. doi: 10.1007/s10156-010-0050-z. [DOI] [PubMed] [Google Scholar]
  • 56.Wang JH, Wang CY, Chi CY, Ho MW, Ho CM, Lin PC. Clinical presentations, prognostic factors, and mortality in patients with Aeromonas sobria complex bacteremia in a teaching hospital: A 5-year experience. J Microbiol Immunol Infect. 2009;42:510–5. [PubMed] [Google Scholar]
  • 57.Dryden M, Munro R. Aeromonas septicaemia: Relationship of species and clinical features. Pathology. 1989;21:111–4. doi: 10.3109/00313028909059546. [DOI] [PubMed] [Google Scholar]
  • 58.Rashid MM, Honda K, Nakai T, Muroga K. An ecological study on Edwardsiella tarda in flounder farms. Fish Pathology. 1994;29:221–7. [Google Scholar]
  • 59.Kim KI, Kang JK, Park JY, Joh SJ, Lee HS, Kwon YK. Phenotypic traits, virulence-associated gene profile and genetic relatedness of Edwardsiella tarda isolates from Japanese eel Anguilla japonica in Korea. Lett Appl Microbiol. 2014;58:168–76. doi: 10.1111/lam.12172. [DOI] [PubMed] [Google Scholar]
  • 60.Joh SJ, Ahn EH, Lee HJ, Shin GW, Kwon JH, Park CG. Bacterial pathogens and flora isolated from farm-cultured eels (Anguilla japonica) and their environmental waters in Korean eel farms. Vet Microbiol. 2013;163:190–5. doi: 10.1016/j.vetmic.2012.11.004. [DOI] [PubMed] [Google Scholar]
  • 61.Meyer FP, Bullock GL. Edwardsiella tarda, a new pathogen of channel catfish (Ictalurus punctatus) Appl Microbiol. 1973;25:155–6. doi: 10.1128/am.25.1.155-156.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Wyatt LE, Ranzell N, Vanderzant C. Edwardsiella tarda in freshwater catfish and their environment. Appl Environ Microbiol. 1979;38:710–4. doi: 10.1128/aem.38.4.710-714.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kawai T, Kusakabe H, Seki A, Kobayashi S, Onodera M. Osteomyelitis due to trimethoprim/sulfamethoxazole-resistant Edwardsiella tarda infection in a patient with X-linked chronic granulomatous disease. Infection. 2011;39:171–3. doi: 10.1007/s15010-011-0080-1. [DOI] [PubMed] [Google Scholar]
  • 64.Muyembe T, Vandepitte J, Desmyter J. Natural colistin resistance in Edwardsiella tarda. Antimicrob Ag Chemother. 1973;4:521–4. doi: 10.1128/aac.4.5.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Marshall BM, Levy SB. Food animals and antimicrobials: Impacts on human health. Clin Microbiol Rev. 2011;24:718–33. doi: 10.1128/CMR.00002-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Waltman WD, Shotts EB. Antimicrobial susceptibilities of Edwardsiella tarda from the United States and Taiwan. Vet Microbiol. 1986;12:277–82. doi: 10.1016/0378-1135(86)90056-8. [DOI] [PubMed] [Google Scholar]

Articles from The Canadian Journal of Infectious Diseases & Medical Microbiology are provided here courtesy of Wiley

RESOURCES